Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study. Yeung DT, Shanmuganathan N, Reynolds J, Branford S, et al. Blood 2024 Aug 5:blood.2024024657. doi: 10.1182/blood.2024024657.

Read + Share

Amedeo Smart

Independent Medical Education

Yeung DT, Shanmuganathan N, Reynolds J, Branford S, et al. Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study. Blood 2024 Aug 5:blood.2024024657. doi: 10.1182/blood.2024024657.
PMID: 39102630